# A Study of Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal Cancer

> **NCT03344614** · PHASE2 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** raltitrexed combined with apatinib

## Key facts

- **NCT ID:** NCT03344614
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2019-01-01
- **Final completion:** 2019-07-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03344614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03344614, "A Study of Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03344614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*